Moleculin Biotech Announces 1-for-20 Reverse Stock Split Effective October 20

• Moleculin Biotech will implement a 1-for-20 reverse stock split effective October 20, 2026, at 12:01 a.m. Eastern Time.
• Shares will begin trading on a split-adjusted basis on Nasdaq that day under the existing ticker MBRX.
• Outstanding common shares will fall from approximately 20,900,000 to 1,050,000; authorized common shares will remain at 500,000,000.
• Fractional shares will be paid in cash rather than issued.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032969), on October 20, 2026, and is solely responsible for the information contained therein.